Julius Middleton Wilder
Medical Instructor in the Department of Medicine
Barrett, NJ, Vann, T, Wilder, J, ingraham, K, Worthy, V, Boyce, X, Reyes, R, Chirinios, M, Wigfall, P, Robinson, W, and Patierno, S. "Implementing a Health Equity Agenda at the Duke Cancer Institute." Oncology Issues September -October 2016 (September 1, 2016): 48-57. Open Access Copy
Wilder, JM, Oloruntoba, OO, Muir, AJ, and Moylan, CA. "Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 22.7 (July 2016): 895-905. Full Text Open Access Copy
Wilder, JM, and Wilson, JAP. "Racial and Ethnic Disparities in Colon Cancer Screening in North Carolina." North Carolina medical journal 77.3 (May 2016): 185-186. Full Text Open Access Copy
Wilder, J, Saraswathula, A, Hasselblad, V, and Muir, A. "A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment." Journal of the National Medical Association 108.1 (February 2016): 24-29. Full Text Open Access Copy
Wilder, JM, Jeffers, LJ, Ravendhran, N, Shiffman, ML, Poulos, J, Sulkowski, MS, Gitlin, N, Workowski, K, Zhu, Y, Yang, JC, Pang, PS, McHutchison, JG, Muir, AJ, Howell, C, Kowdley, K, Afdhal, N, and Reddy, KR. "Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data." Hepatology (Baltimore, Md.) 63.2 (February 2016): 437-444. Full Text Open Access Copy
Wilder, JM, and Muir, AJ. "Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes." Therapeutic advances in chronic disease 6.6 (November 2015): 314-327. (Review) Full Text Open Access Copy
Wilder, J, and Patel, K. "The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease." Medical devices (Auckland, N.Z.) 7 (January 2014): 107-114. (Review) Full Text Open Access Copy
Wilder, J, Henson, J, Patel, Y, Zheng, J, Chow, S-C, and Muir, A. "Racial Differences in Phenotype and Outcome Among Patients with Primary Sclerosing Cholangitis Listed for Liver Transplant." October 2016.
Henson, JB, Wilder, JM, Patel, YA, Zheng, J, Chow, S-C, King, LY, and Muir, AJ. "Phenotypic Differences in Primary Sclerosing Cholangitis by Age Group." October 2016.
Patel, YA, Henson, JB, Wilder, JM, Zheng, J, Chow, S-C, Berg, CL, and Muir, AJ. "The Impact of HLA Serotyping and HLA Matching for PSC, PSC/AIH, AIH, PBC/AIH, and PBC Patients on Post-Liver Transplant Graft Failure: an Analysis of the UNOS Database." October 2016.
Matta, B, Wilder, JM, Lee, T-H, and Patel, K. "Predictive value of APRI and FIB4 scores for liver fibrosis assessment in comparison to Transient Elastography in chronic hepatitis C patients." October 2015.
Matta, B, Wilder, J, Lee, T-H, and Patel, K. "Predictive Performance of FIB 4 and APRI for Liver Fibrosis Assessment in Hepatitis C in Comparison to Transient Elastography." October 2015.
Jeffers, LJ, Wilder, JM, Muir, AJ, Howell, C, Zhu, Y, Seyedkazemi, S, Yang, JC, Pang, PS, McHutchison, JG, and Reddy, KR. "Safety and Efficacy of Ledipasvir/Sofosbuvir Single-Tablet-Regimen in African Americans with Genotype 1 Chronic Hepatitis C Virus: A Retrospective Analysis of Phase 3 Studies." 2014.
Oloruntoba, OO, Wilder, JM, Smith, AD, Muir, AJ, and Moylan, CA. "The Influence of Race on Patient Preferences and Access to Orthotopic Liver Transplantation and Organ Donation." 2014.
Saraswathula, A, Wilder, JM, and Muir, AJ. "A Systematic Review of Racial and Ethnic Diversity of Hepatitis C Virus Clinical Trials." October 2012.